The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-Chloro-4-((2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)amino)benzoic acid ID: ALA4101332
Chembl Id: CHEMBL4101332
PubChem CID: 137660772
Max Phase: Preclinical
Molecular Formula: C14H10ClN3O3
Molecular Weight: 303.71
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1
Standard InChI: InChI=1S/C14H10ClN3O3/c15-9-5-7(13(19)20)1-3-10(9)16-8-2-4-11-12(6-8)18-14(21)17-11/h1-6,16H,(H,19,20)(H2,17,18,21)
Standard InChI Key: MLOIKHJGUWDUCY-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 303.71Molecular Weight (Monoisotopic): 303.0411AlogP: 2.95#Rotatable Bonds: 3Polar Surface Area: 97.98Molecular Species: ACIDHBA: 3HBD: 4#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.48CX Basic pKa: ┄CX LogP: 2.85CX LogD: 0.02Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.60Np Likeness Score: -1.43
References 1. Yasui T, Yamamoto T, Sakai N, Asano K, Takai T, Yoshitomi Y, Davis M, Takagi T, Sakamoto K, Sogabe S, Kamada Y, Lane W, Snell G, Iwata M, Goto M, Inooka H, Sakamoto JI, Nakada Y, Imaeda Y.. (2017) Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design., 25 (17): [PMID:28760529 ] [10.1016/j.bmc.2017.07.037 ]